3 results
Approved WMOPending
To evaluate the efficacy of crovalimab compared to eculizumab
Approved WMORecruiting
The primary objective of this study is to evaluate in patients suffering from diffuse cutaneous SSc (DcSSc) the effect of 800mg and 1200mg IVA337 daily on the skin compared to placebo. The modified Rodnan Skin Score (MRSS) will be used to determine…
Approved WMOPending
To evaluate the safety and tolerability of crovalimab compared witheculizumab